Avitene Sheets

Microfibrillar Collagen Hemostat Sheets (Non-Woven Web)

Avitene™ Sheets

Standardise on the proven solution for active hemostasis.

Avitene Microfibrillar Collagen Hemostat is an active absorbable collagen hemostat, proven to accelerate clot formation. Avitene effectively enhances platelet aggregation and the release of proteins to form fibrin, resulting in hemostasis.

MULTIPLE FORMS FOR EVERY SPECIALTY:

  • The proven solution for controlling bleeding in all surgical applications, including neurosurgery, urology, cardiovascular and general surgery1
  • Trusted by surgeons for its safety and efficacy for over 40 years

Avitene™ Sheets (Nonwoven web)

  • Avitene™ Sheets provide the same efficacy expected from Avitene™ Flour
  • Cut to any shape or size
  • Clings tenaciously to hemorrhage
  • Ideal for use on flat surfaces or to wrap vessels and anastomosis sites
  • Available in 3.5 cm x 3.5 cm, 7.0 cm x 3.5 cm and 7.0 cm x 7.0 cm

AVITENE™ SHEETS

Avitene™ Microfibrillar Collagen Hemostat Flour

  • Effective in controlling arterial bleeding1
  • Conforms and adheres to irregular spaces
  • Easy removal with irrigation and suction
  • Available in 0.5 g, 1.0 g and 5.0 g sizes

AVITENE™ FLOUR image

Avitene™ Ultrafoam™ Collagen Sponge

  • Easy, effective solution for hemostasis
  • In an animal study, UltraFoam™ Collagen without thrombin was as effective as Gelfoam® Sponge with thrombin
  • Reduced thrombin usage may lower cost
  • Soft, pliable sponge is ready-to-use out of the package
  • No soaking necessary
  • Does not swell, providing predictable placement of Ultrafoam™

SYRINGEAVITENE™ COLLAGEN HEMOSTAT image

SKU/REF SKU/REF Name Packaging
1010080 Avitene Sheets  3.5 cm x 3.5 cm (1.4" x 1.4") 6/cs
1010090 Avitene Sheets 7.0 cm x 3.5 cm (2.75" x 1.4") 6/cs
1010110 Avitene Sheets 7.0 cm x 7.0 cm (2.75" x 2.75") 6/cs

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

Animal data may not correlate to outcomes in humans. Data on file.

INDICATIONS

Avitene (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

CONTRAINDICATIONS

  • Avitene (MCH) should not be used in the closure of skin incisions as it may interfere with the healing of the skin edges. This is due to simple mechanical interposition of dry collagen and not to any intrinsic interference with wound healing.
  • By filling porosities of cancellous bone, MCH may significantly reduce the bond strength of methylmethacrylate adhesives. MCH should not, therefore, be employed on bone surfaces to which prosthetic materials are to be attached with methylmethacrylate adhesives.

WARNINGS

  • Avitene (MCH) is inactivated by autoclaving.
  • Ethylene oxide reacts with bound hydrochloric acid to form ethylene chlorohydrin.
  • This device has been designed for single use only.
  • Reuse, reprocessing, resterilization or repackaging may compromise the structural integrity and/or essential material and design characteristics that are critical to the overall performance of the device and may lead to device failure which may result in injury to the patient.
  • Reuse, reprocessing, resterilization or repackaging may also create a risk of contamination of the device and/ or cause patient infection or cross infection, including, but not limited to, the transmission of infectious diseases from one patient to another.
  • Contamination of the device may lead to injury, illness or death of the patient or end user.
  • MCH is not for injection or intraocular use.
  • Moistening MCH or wetting with saline or thrombin impairs its hemostatic efficacy. It should be used dry. Discard any unused portion. As with any foreign substance, use in contaminated wounds may enhance infection.

ADVERSE REACTIONS

  • The most serious adverse reactions reported which may be related to the use of Avitene (MCH) are potentiation of infection including abscess formation, hematoma, wound dehiscence and mediastinitis.
  • Other reported adverse reactions possibly related are adhesion formation, allergic reaction, foreign body reaction and subgaleal seroma (report of a single case).
  • The use of MCH in dental extraction sockets has been reported to increase the incidence of alveolalgia.
  • Transient laryngospasm due to aspiration of dry material has been reported following use of MCH in tonsillectomy.

Please consult package insert for more detailed safety information and instructions for use.

References
  1. See full Instructions for Use for detailed application instructions

BD-52022

Go to top